DIGIPHARM

DIGIPHARM



Foto Digipharm.


Abstract

Digipharms’ solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient.

In healthcare today, there is a lack of incentive for health
systems and providers to focus on mutually beneficial collaboration and the maximisation of patient outcomes.

Vision

Digipharms’ vision is to be ‘the pioneer of value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry’ using revolutionary blockchain technology.

Digipharm aims to utilise innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare.


Problem

Barriers to innovative pricing and ‘paying for performance’

Healthcare systems are often required to make the difficult decision of whether to reimburse costly pharmacological therapies and provide access for patients while taking into account their limited resources.

Innovative pricing approaches have the ability to overcome the challenges faced by healthcare systems when assessing the funding of new drugs, to enable the implementation of
‘flexible’ pricing schemes to assess the price of treatment in relation to the benefits it delivers.

Unfortunately, healthcare systems around the world lack the relevant infrastructure to track and implement innovative pricing models such as value-based pricing agreements, and so are reluctant to adopt such innovative policies. This results in novel pharmacological therapies being denied to patients who are most at need, an opportunity missed to decrease the long term economic and disease burden on health systems, and a barrier to reimbursement for manufacturers.

Limitations of conventional real world evidence

Real world evidence (RWE) is playing an increasingly influential role in informing decision making within the healthcare industry and is crucial to informing value-based healthcare. Yet the delay of RWE outputs, the expenses of data access and the current methods of data collection
negate many of the benefits of utilising these rich data resources.

The lack of easily accessible and comprehensive RWE currently prevents stakeholders in healthcare to evaluate the real time performance and value provided by therapy in real life clinical practice as part of a value-based healthcare delivery system.

Solutions

Insights

The Insights platform will extract anonymised patient level data from the Reimburse platform and health information systems to the world’s first ‘live’ RWE database. Insights will provide a symbiotic solution with Reimburse to complement the progressive transformation towards value-based healthcare delivery systems.

The development of a ‘live’ evidence repository will allow the integration of knowledge back into the delivery system in real time to facilitate decision making, drug development and health related research. Patients will be incentivised to contribute their health information to the Insights platform and will gain access to valuable health information that is currently unattainable.

Reimburse

The Reimburse platform harnesses the benefits of automated ‘smart contracts’ and blockchain technology; facilitating the application of truly dynamic innovative pricing solutions between healthcare systems and manufacturers, in a secure and compliant fashion with minimal administrative burden.

Use of the Reimburse platform will expedite integration, coordination and delivery of patient centric healthcare systems with a focus on improving patient outcomes while accelerating ‘payment for value‘ mechanisms between payers and manufacturers using neutrally-enforceable agreements in a peer to peer fashion.

Goals

To remove infrastructural barriers and automate the implementation of innovative value-based pricing agreements on a fully independent platform; in order to facilitate personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.

To develop the world’s first ‘live’ RWE platform. Allowing the utilisation of real world data (RWD) as soon as it becomes
available, to inform health related research, decision making and to incentivise patients to contribute their data.

DPH Token

Digipharm (DPH) tokens will be used to pay license/access fees on Digipharm platforms. Access fees will invariably be determined and stipulated in USD value and the quantity of tokens required will depend on the type of access (manufacturer, patient, payer or provider) combined
with the form of interaction required. The quantity of tokens required for such interactions is subject to change, relative to the market value of DPH.


DPH Token Characteristics

DPH Supply: 100,000,000 Fixed (ERC-20)
» Ticker code: DPH
» Decimal Places: 18
» Token Price 1.00 USD

DPH Token Sale Information


Funding Usage And Token Distribution


Commitment To Charitable Causes

0.5% of ICO proceeds will be allocated to the Digipharm charitable foundation (to be established) with the goal to develop sustainable health related services in third world countries. Digipharm will further commit 2.5% of net profits per annum towards the charitable foundation. If the foundation cannot be established due to regulatory or legal reasons, Digipharm intends to allocated the above mentioned funds to a third party foundation with similar goals.

I can say that Digipharm is a good ICO program. Think business is pretty fantastic. It attracts people regularly.
Experienced and skilled cooperation is difficult to achieve.
We can build the ability to achieve goals.

Who We Work With



More Information Visit The Digipharm Link:


Author : Eslilin667

Komentar

Postingan populer dari blog ini

ICO KOI

BILLCRYPT

BECENT